Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Export 10 results:
Συντάκτης Τίτλος Τύπος [ Έτος] Φίλτρα: Συντάκτης is Tikas, Ioannis [Clear All Filters]
Pathogenic mutations and overall survival in 3,084 patients with cancer: the Hellenic Cooperative Oncology Group Precision Medicine Initiative..
Oncotarget. 11(1), 1-14.
(2020). Is There an Independent Role of TERT and NF1 in High Grade Gliomas?.
Transl Oncol. 13(2), 346-354.
(2020). Genetic mapping of pancreatic cancer by targeted next-generation sequencing e.
ESMO Open. 4(5), e000525.
(2019). Pathogenic BRCA1 mutations may be necessary but not sufficient for tissue genomic heterogeneity: Deep sequencing data from ovarian cancer patients..
Gynecol Oncol. 152(2), 375-386.
(2019). Relapsed and De Novo Metastatic HER2-positive Breast Cancer Treated With Trastuzumab: Tumor Genotypes and Clinical Measures Associated With Patient Outcome..
Clin Breast Cancer. 19(2), 113-125.e4.
(2019). AMALTHEA: Prospective, Single-Arm Study of the Hellenic Cooperative Oncology Group (HeCOG) Evaluating Efficacy and Safety of First-Line FOLFIRI + Aflibercept for 6 Months Followed by Aflibercept Maintenance in Patients With Metastatic Colorectal Cancer..
Clin Colorectal Cancer. 17(4), e631-e637.
(2018). Genotyping and mRNA profiling reveal actionable molecular targets in biliary tract cancers..
Am J Cancer Res. 8(1), 2-15.
(2018). Prevalent somatic BRCA1 mutations shape clinically relevant genomic patterns of nasopharyngeal carcinoma in Southeast Europe..
Int J Cancer. 142(1), 66-80.
(2018). Prognostic significance of tumor genotypes and CD8+ infiltrates in stage I-III colorectal cancer..
Oncotarget. 9(86), 35623-35638.
(2018). The fate of BRCA1-related germline mutations in triple-negative breast tumors..
Am J Cancer Res. 7(1), 98-114.
(2017).